LOS ANGELES, Sept 12 (Reuters) - Dusa Pharmaceuticals Inc. (DUSA.O: Quote, Profile, Research) said on Tuesday that the company contracted to manufacture its acne drug, Nicomide, has received a warning letter from the U.S. Food and Drug Administration, which has never formally approved the drug.
